Seattle Genetics Reports First Quarter 2013 Financial Results
Thursday, May 09, 2013
Total revenues of $57.3 million, including $33.9 million in ADCETRIS® (Brentuximab Vedotin) net product sales.
AstraZeneca and BMS Receive Award from Major Medical Association
Thursday, May 09, 2013
Companies received the American College of Endocrinology (ACE) Philanthropic Award at the AACE 22nd Annual Scientific & Clinical Congress in Phoenix, Arizona on May 4, 2013.
BIO to Use ViS Analytics to Streamline Pediatric Clinical Research
Thursday, May 09, 2013
Pediatric research is essential to study the effects of new therapeutics in children.
Liaison Healthcare Launches Global CRO Integration Hub
Thursday, May 09, 2013
New cloud-based solution facilitates information exchange during clinical trial process.
Enzo and NIH File Patent Application for Autoimmune Diseases
Thursday, May 09, 2013
Collaborators filed a patent application for the management of autoimmune diseases that may include age-related macular degeneration (AMD), which is a leading cause of blindness in the United States.
Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's
Thursday, May 09, 2013
Phase III clinical study of immunoglobulin (IG) did not meet its co-primary endpoints of reducing cognitive decline and preserving functional abilities in patients with mild to moderate Alzheimer’s disease.
Aileron Therapeutics Successfully Completes First-Ever Stapled Peptide Clinical Trial
Thursday, May 09, 2013
Safety and pharmacokinetics of ALRN-5281, a long-acting growth-hormone-releasing-hormone agonist, established in single-ascending dose study.
Aeras, Oxford University, Okairos: TB, HIV and Malaria Vaccine Research Gets Major Boost
Thursday, May 09, 2013
$2.9 million grant to advance chimpanzee adenovirus platform.
BioSante Pharmaceuticals and ANI Pharmaceuticals Plan Merger
Thursday, May 09, 2013
BioSante also announces record date for contingent value rights distribution.
|
|
|
|
|
|
